Centaurus Financial, Inc. Merrimack Pharmaceuticals Inc Transaction History

Centaurus Financial, Inc.

  • $1.44 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 05, 2018
SELL
$3.91 - $4.66 $7 - $9
-2 Closed
0 $0
Q2 2018

Aug 15, 2018
BUY
$3.86 - $7.61 $7 - $15
2 New
2 $0

Others Institutions Holding MACK

# of Institutions
1
Shares Held
77
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Centaurus Financial, Inc. Portfolio

Follow Centaurus Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Centaurus Financial, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email